Czernobilsky H, Fiehn W, Ziegler R
Klin Wochenschr. 1985 Jun 3;63(11):518-22. doi: 10.1007/BF01747982.
Angiotensin-converting enzyme (ACE) was measured in plasma of patients with Graves' disease and with toxic nodular goiter, as well as in their treated counterparts and in normal controls. A significant elevation of ACE levels and a positive correlation between ACE, thyroxine, and triiodothyronine levels was found in both groups of thyrotoxicosis. Parallel fluctuations of triiodothyronine and ACE levels, albeit with a certain lag of the latter, was observed in patients in whom multiple measurements were taken. ACE levels, which were also determined in hypothyroid patients and in patients with euthyroid goiter on suppression therapy, were in the same range as normal controls and as in treated thyrotoxic patients. We conclude that the pathogenesis of thyrotoxicosis does not play a role in ACE elevation but that increased thyroid hormone seems to induce elevation of ACE. ACE elevation in thyrotoxicosis may constitute an integral part of the renin-angiotensin axis.
在格雷夫斯病患者、毒性结节性甲状腺肿患者及其接受治疗后的对应患者以及正常对照者的血浆中测量了血管紧张素转换酶(ACE)。在两组甲状腺毒症患者中均发现ACE水平显著升高,且ACE、甲状腺素和三碘甲状腺原氨酸水平之间呈正相关。在进行多次测量的患者中,观察到三碘甲状腺原氨酸和ACE水平呈平行波动,尽管后者有一定延迟。在甲状腺功能减退患者和接受抑制治疗的甲状腺功能正常的甲状腺肿患者中也测定了ACE水平,其水平与正常对照者以及接受治疗的甲状腺毒症患者相同。我们得出结论,甲状腺毒症的发病机制在ACE升高中不起作用,但甲状腺激素增加似乎会诱导ACE升高。甲状腺毒症中的ACE升高可能是肾素 - 血管紧张素轴的一个组成部分。